全球醫護站(POC)診斷市場 是由出版商BCC Research在2012年01月所出版的。
這份英文市場調查報告書包含186 Pages 價格從美金4850起跳。
2010年全球醫護站(POC)診斷市場達到134億美元，2011年預計達到138億美元。預計該市場今後將以3.7％擴大，2016年將達到165億美元。
本報告提供全球醫護站(POC)診斷市場現況與未來預測(∼2016年)，成長的因素和課題，主要加入企業簡介等等，為您概述為以下內容。
第1章 簡介
第2章 摘要
第3章 產業概要
- POC檢驗是什麼
- POC市場概要
- 臨床診斷產業結構的POC
- POC檢驗網站
- POC產品的分類
- 一般的POC檢驗
- 美國的CLIA的重要性
- 其他的法規機關
- HIV/AIDS檢驗的倡導提議
- POC市場發展因素
- 藥物濫用相關關注
第4章 POC市場
- 市場概要
- 企業的市場佔有率
- 市場結構
- 市場零件
- 血液化學·電解質檢驗
- 心臟標誌物檢驗
- 膽固醇檢驗
- 藥物·酒精中毒檢驗
- 血糖值檢驗
- 傳染病檢查
- 妊娠·妊娠能力檢驗
- 血色素/止血
- 腫瘤標幟（癌症篩檢）檢驗
- 尿化學檢驗
- MISC檢驗
第5章 技術應用程式
- 生物感應器
- 電極
- 持續檢驗
- 即時HIV檢驗
- 藥物檢驗
- 專利分析
第6章 全球POC市場
第7章 主要企業簡介
第8章 附錄
Abstract
REPORT HIGHLIGHTS
- The global point-of-care (POC) diagnostics market reached $13.4 billion in
2010 and is expected to reach $13.8 billion in 2011. It will further grow to
$16.5 billion in 2016 for a compound annual growth rate (CAGR) of 3.7% between
2011 and 2016.
- The glucose monitoring segment of the POC market reached $7.6 billion in
2010 and is expected to decrease falling to $7.5 billion in 2011. It will grow
to $7.6 billion in 2016 for a CAGR of 0.3% between 2011 and 2016.
- The blood chemistry and electrolyte segment of the POC market reached $2.2
billion in 2010 and is expected to reach $2.3 billion in 2011. It will further
grow to $2.8 billion in 2016 for a CAGR of 4.8% between 2011 and 2016.
SUMMARY FIGURE
FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE,
2009-2016 ($ MILLIONS)
Source: BCC Research
STUDY GOALS AND OBJECTIVES
The goal of this study on the point-of-care (POC) industry is to describe this
flourishing near-patient testing market. This report provides a complete
review and analysis of the current POC markets, and forecasts the market
through 2016 in constant dollars. In addition, it provides an examination and
description of select products, current and emerging technologies, and company
profiles.
The study also covers issues regarding regulation of POC testing,
international developments, and patents for POC testing technologies.
REASONS FOR DOING THE STUDY
Over the last few decades, there has been a strong trend toward POC testing
due to an increasing demand for near-patient testing that provides rapid
results. More tests are being performed at the hospital patient's bedside, in
physicians' office laboratories, outpatient clinics, emergency rooms, and
intensive-care units. Critical-care instruments combining selected important
chemistry, hematology, and hemostasis parameters have entered the market for
POC testing in the emergency and operating rooms.
The wider availability of POC testing has revolutionized the continuum of the
patient-care process by providing laboratory results rapidly and efficiently
at these locations. The trend toward greater POC testing is driven by the
faster diagnostic benefits it provides.
Several reasons have emerged for this demand of POC testing, including staff
shortages, older populations, long-term cost savings, faster diagnosis and
care, and rural locations without conventional laboratory services. This
study will address these areas and others.
SCOPE OF REPORT
This study will describe the market for POC diagnostics at the global level.
It focuses on the accelerating growth in this important diagnostic market
segment and the key industry players.
Specifically, the report:
- Describes the POC industry
- Estimates the current and future market size
- Provides breakdowns for U.S. markets
- Describes product segments and the continuous updating of POC products
- Analyzes market influences in the industry and predicts the changes that
will shape the future POC market
- Discusses trends within the market and provides a future outlook
- Reviews business activities of market leaders
- Lists patents for POC technologies
DEFINING POC
For the purpose of this study, POC testing includes those tests that are used
outside the traditional laboratory. This can be a range of users, including
patients, physicians, outpatient clinics, community health centers, and
pharmacies. Tests included in this report are those that do not require any
specialized training to perform, are performed easily, and whose results are
produced in a minimal time frame.
Some other terms often used to describe POC include:
- Waived tests
- Rapid tests
- Near patient testing
- Bedside testing
- Outpatient testing
METHODOLOGY
The information for this BCC report was obtained through primary and secondary
data-collection methods. Primary methods included interviews with key
representatives in the industry such as product development managers, clinical
specialists, government departments, and other key representatives involved in
the diagnostic industry.
Secondary methods included published literature, investment reports, company
literature, and various business journals that focus on diagnostic products
and technologies.
Market data for this report pertains to the worldwide market, with specific
U.S. data included. All information is displayed using U.S. dollars at the
manufacturers' level. The base year of the report is 2011, with historical
data provided for 2009 and 2010 and forecast data provided through 2016.
Historical, base year, and forecast data are provided for each of the ten
market segments in the report. Compound annual growth rates (CAGRs) are
determined through a compilation of data, including past trends, future
trends, demographics, incidence of disease, products in research and
development, current product growth, and trends in government regulations.
Competitor market share estimates are provided for each market segment for the
2011 base year.
ANALYST CREDENTIALS
Melissa Elder is an experienced healthcare market analyst specializing
in prescription and over-the-counter pharmaceuticals, medical devices, and
emerging healthcare technologies. Ms. Elder has nearly 20 years of experience
in the healthcare industry, specializing in market research for the past 14
years. This experience has given her substantial insight into pharmaceutical
market analysis. Her work in the medical community, including emergency room
medical training and healthcare information system coordination, has enhanced
her ability to provide insight into many healthcare markets.
Table of Contents
Point of Care Diagnostics
Chapter - 1: INTRODUCTION - Complimentary
- STUDY GOALS AND OBJECTIVES
- REASONS FOR DOING THE STUDY
- SCOPE OF REPORT
- DEFINING POC
- METHODOLOGY
- ANALYST CREDENTIALS
- RELATED REPORTS
- BCC ON-LINE SERVICES
- DISCLAIMER
Chapter - 2: SUMMARY
- OVERVIEW
- MAJOR FINDINGS
- Table 0: FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, THROUGH 2016
- Figure 0: FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, 2009-2016
Chapter - 3: INDUSTRY OVERVIEW
- WHAT IS POC TESTING?
- OVERVIEW OF POC MARKET
- POC AS PART OF CLINICAL DIAGNOSTICS INDUSTRY STRUCTURE
- POC TESTING SITES
- POC PRODUCT SEGMENTS
- COMMONLY PERFORMED POC TESTS
- SIGNIFICANCE OF CLIA IN THE UNITED STATES
- OTHER REGULATORY AGENCIES
- INITIATIVE FOR HIV/AIDS TESTING
- DRIVING FORCES OF THE POC MARKET
- NEW ATTENTION TO DRUGS OF ABUSE
Chapter - 4: THE POC MARKET
- MARKET OVERVIEW
- COMPETITOR MARKET SHARE
- MARKET STRUCTURE
- MARKET COMPONENTS
Chapter - 5: TECHNOLOGY APPLICATIONS
- BIOSENSORS
- ELECTRODES
- CONTINUOUS TESTING
- RAPID HIV TESTS
- DRUG TESTING
- PATENT ANALYSIS
Chapter - 6: WORLDWIDE POC MARKET
- MARKET SIZE
- GLOBAL MARKET SHARES
- PRESENCE OF MANUFACTURERS IN THE WORLDWIDE MARKET
- Table 64: MARKET SHARE OF MAJOR POC MARKET PARTICIPANTS, 2011
- Figure 40: MARKET SHARE MAJOR POC MARKET PARTICIPANTS, 2011
Chapter - 7: PROFILES OF MAJOR MARKET PARTICIPANTS
- OVERVIEW OF MARKET PARTICIPANTS
- COMPANY PROFILES
Chapter - 8: APPENDIX
- KEY SOURCES OF INFORMATION
List of Tables
- Summary Table: FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, THROUGH 2016
- Table 1: SELECTED KEY STATISTICS FOR POC TESTING SITES
- Table 2: NUMBER OF HOSPITALS FOR SELECTED COUNTRIES, 2009
- Table 3: NUMBER OF U.S. HEALTHCARE FACILITIES BY TYPE, 2009*
- Table 4: SELECTED POC TESTS - CLIA WAIVED
- Table 5: PERTINENT PARAMETERS OF GMP REGULATIONS AFFECTING IN VITRO
DIAGNOSTICS
- Table 6: HEALTH EXPENDITURES AS PERCENTAGE OF GDP BY COUNTRY: 1980-2008
- Table 7: HOSPITAL USAGE STATISTICS, AVERAGE, 2000-2010
- Table 8: WORLD HEALTH ORGANIZATION RANKING OF HEALTHCARE SYSTEMS, TOP 50,
2000
- Table 9: STATISTICS OF SELECTED DISEASES IN THE GLOBAL POPULATION,
2009-2010 ESTIMATES
- Table 10: BIRTH RATES AND BIRTHS BY COUNTRY, 2010 ESTIMATES
- Table 11: GLOBAL POPULATION AND ANNUAL GROWTH BY SELECTED AGE GROUP AND
SELECTED YEARS, THROUGH 2030
- Table 12: GLOBAL POPULATION BY SELECTED COUNTRY, THROUGH 2015
- Table 13: GLOBAL FORECAST FOR THE POC MARKET, THROUGH 2016
- Table 14: MARKET SHARE OF MAJOR POC MARKET PARTICIPANTS, 2011
- Table 15: FORECAST OF THE GLOBAL POC BLOOD GAS/ELECTROLYTE TESTING MARKET,
THROUGH 2016
- Table 16: RELATIVE MARKET SHARE OF POC BLOOD CHEMISTRY ANALYZER
MANUFACTURERS, 2011
- Table 17: NOVA BIOCHEMICAL POC STAT PROFILE PHOX SERIES BY AVAILABLE TESTS
- Table 18: NOVA BIOCHEMICAL POC STAT PROFILE CCX SERIES BY AVAILABLE TESTS
- Table 19: FORECAST OF THE GLOBAL POC CARDIAC MARKER TESTING MARKET,
THROUGH 2016
- Table 20: RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS, 2011
- Table 21: FORECAST OF THE GLOBAL CHOLESTEROL POC RAPID TEST MARKET,
THROUGH 2016
- Table 22: RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST
MANUFACTURERS, 2011
- Table 23: RECENT (2010-2011) CLIA-WAIVED APPROVED CHOLESTEROL TESTS
- Table 24: FORECAST OF THE GLOBAL DRUG AND ALCOHOL POC RAPID TEST MARKET,
THROUGH 2016
- Table 25: RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST
MANUFACTURERS, 2011
- Table 26: RECENT (2010-2011) CLIA-WAIVED APPROVED POC DRUG AND ALCOHOL
SCREENING TESTS
- Table 27: FORECAST OF THE GLOBAL POC GLUCOSE METER MARKET, THROUGH 2016
- Table 28: MARKET SHARE FOR THE GLOBAL POC GLUCOSE METER MARKET BY
COMPONENT, 2011
- Table 29: RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES
MANUFACTURERS, 2011
- Table 30: RECENT (2010-2011) CLIA-WAIVED APPROVED BLOOD GLUCOSE METERS
- Table 31: SELECTED LISTING OF RETAILERS SELLING HOME DIAGNOSTIC'S METERS
- Table 32: SELECT LISTING OF BLOOD GLUCOSE MONITORS CAPABLE OF INTERACTING
WITH COMPUTER SOFTWARE
- Table 33: RECENT (2010-2011) CLIA-WAIVED APPROVED STREP A TESTS
- Table 34: RECENT (2010-2011) CLIA-WAIVED APPROVED INFLUENZA TESTS
- Table 35: RECENT (2010 - 2011) CLIA-WAIVED APPROVED RSV TESTS
- Table 36: RECENT (2010-2011) CLIA-WAIVED APPROVED HIV TESTS
- Table 37: RECENT (2010-2011) CLIA-WAIVED APPROVED INFECTIOUS MONONUCLEOSIS
TESTS
- Table 38: RECENT (2010 - 2011) CLIA-WAIVED APPROVED H. PYLORI TESTS
- Table 39: FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST MARKET,
THROUGH 2016
- Table 40: MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY
TEST TYPE, 2011
- Table 41: RELATIVE MARKET SHARE OF INFECTIOUS DISEASE POC RAPID TEST
MANUFACTURERS, 2011
- Table 42: FORECAST OF THE GLOBAL PREGNANCY/FERTILITY POC RAPID TEST
MARKET, THROUGH 2016
- Table 43: MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY
TEST TYPE, 2011
- Table 44: RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST
MANUFACTURERS, 2011
- Table 45: RECENT (2010-2011) CLIA-WAIVED APPROVED PREGNANCY TESTS
- Table 46: FORECAST OF THE GLOBAL HEMOGLOBIN/HEMOSTASIS POC RAPID TEST
MARKET, THROUGH 2016
- Table 47: RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST
MANUFACTURERS, 2011
- Table 48: RECENT (2010-2011) CLIA-WAIVED APPROVED HEMATOLOGY TESTS
- Table 49: FORECAST OF THE GLOBAL TUMOR MARKER POC RAPID TEST MARKET,
THROUGH 2016
- Table 50: RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST
MANUFACTURERS, 2011
- Table 51: RECENT (2010-2011) CLIA-WAIVED APPROVED FECAL OCCULT BLOOD TESTS
- Table 52: RECENT (2010-2011) CLIA-WAIVED APPROVED BLADDER TESTS
- Table 53: FORECAST OF THE GLOBAL POC URINE CHEMISTRY ANALYZER MARKET,
THROUGH 2016
- Table 54: RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER
MANUFACTURERS, 2011
- Table 55: RECENT (2010-2011) CLIA-WAIVED APPROVED URINE CHEMISTRY ANALYZERS
- Table 56: RECENT (2010-2011) CLIA-WAIVED APPROVED VAGINAL PH TESTS
- Table 57: RECENT (2010-2011) CLIA-WAIVED APPROVED TSH TESTS
- Table 58: RECENT (2010-2011) CLIA-WAIVED APPROVED MALE REPRODUCTIVE TESTS
- Table 59: RESULTS OF U.S. PATENT SEARCH FOR POC CATEGORIES, JANUARY 2009
TO NOVEMBER 2011
- Table 60: U.S. PATENTS BY SUBJECT AREA, JANUARY 2009 TO NOVEMBER 2011
- Table 61: PATENT ASSIGNEES BY COUNTRY, JANUARY 2009 TO NOVEMBER 2011
- Table 62: GLOBAL FORECAST FOR THE POC MARKET, THROUGH 2016
- Table 63: POC GLOBAL MARKET SHARE BY REGION, 2011
- Table 64: MARKET SHARE OF MAJOR POC MARKET PARTICIPANTS, 2011
- Table 65: ABAXIS' COMPANY REVENUES, 2006-2010*
- Table 66: ABBOTT'S COMPANY REVENUES, 2006-2010
- Table 67: ALERE'S COMPANY REVENUES, 2006-2010
- Table 68: BECKMAN COULTER'S COMPANY REVENUES, 2006-2010
- Table 69: BECTON DICKINSON'S COMPANY REVENUES, 2006-2011*
- Table 70: CHURCH & DWIGHT'S COMPANY REVENUES, 2006-2010
- Table 71: DANAHER'S COMPANY REVENUES, 2006-2010
- Table 72: QUEST'S COMPANY REVENUES, 2006-2010
- Table 73: ITC'S COMPANY SALES, 2008-2010
- Table 74: JOHNSON & JOHNSON'S COMPANY REVENUES, 2006-2010
- Table 75: NIPRO CORPORATION'S COMPANY REVENUES, 2006-2010*
- Table 76: ORASURE'S COMPANY REVENUES, 2006-2010
- Table 77: QUIDEL'S COMPANY REVENUES, 2006-2010
- Table 78: ROCHE GROUP'S REVENUES, 2006-2010
- Table 79: SEKISUI CHEMICAL CO'S REVENUES, 2006-2010
- Table 80: SIEMENS' COMPANY REVENUES, 2006-2010
- Table 81: SPECTRAL'S COMPANY REVENUES, 2007-2010
- Table 82: TRINITY'S COMPANY REVENUES, 2006-2010
List of Figures
- Summary Figure: FORECAST OF THE GLOBAL POC MARKET BY TEST TYPE, 2009-2016
- Figure 1: HEALTH EXPENDITURES AS PERCENT OF GDP BY COUNTRY, 1980-2008
- Figure 2: HOSPITAL USAGE STATISTICS
- Figure 3: BIRTH RATES AND BIRTHS BY COUNTRY, 2010 ESTIMATES
- Figure 4: GLOBAL POPULATION BY SELECTED AGE GROUP AND SELECTED YEARS, 2000
- 2030
- Figure 5: GLOBAL POPULATION BY SELECTED COUNTRY, 2010 AND PROJECTED 2015
- Figure 6: GLOBAL FORECAST FOR THE POC MARKET, 2009-2016
- Figure 7: DISTRIBUTION OF SALES FOR THE GLOBAL POC MARKET BY TEST TYPE,
2011
- Figure 8: MARKET SHARE MAJOR POC MARKET PARTICIPANTS, 2011
- Figure 9: DISTRIBUTION CHANNELS: POC DIAGNOSTIC DEVICES
- Figure 10: FORECAST OF THE GLOBAL POC BLOOD GAS/ELECTROLYTE TESTING
MARKET, 2009-2016
- Figure 11: RELATIVE MARKET SHARE BLOOD GAS ANALYZER MANUFACTURERS, 2011
- Figure 12: FORECAST OF THE GLOBAL POC CARDIAC MARKER TESTING MARKET,
2009-2016
- Figure 13: RELATIVE MARKET SHARE OF POC CARDIAC MARKER MANUFACTURERS, 2011
- Figure 14: FORECAST OF THE GLOBAL CHOLESTEROL POC RAPID TEST MARKET,
2009-2016
- Figure 15: RELATIVE MARKET SHARE OF CHOLESTEROL POC RAPID TEST
MANUFACTURERS, 2011
- Figure 16: FORECAST OF THE GLOBAL DRUG AND ALCOHOL POC RAPID TEST MARKET,
THROUGH 2016
- Figure 17: RELATIVE MARKET SHARE OF DRUG AND ALCOHOL POC RAPID TEST
MANUFACTURERS, 2011
- Figure 18: FORECAST OF THE GLOBAL POC GLUCOSE METER MARKET, 2009-2016
- Figure 19: MARKET SHARE FOR THE GLOBAL POC GLUCOSE METER MARKET BY
COMPONENT, 2011
- Figure 20: RELATIVE MARKET SHARE FOR GLUCOSE METERS AND SUPPLIES
MANUFACTURERS, 2011
- Figure 21: FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST
MARKET, THROUGH 2016
- Figure 22: MARKET SHARE FOR THE GLOBAL POC INFECTIOUS DISEASE MARKET BY
TEST TYPE, 2011
- Figure 23: RELATIVE MARKET SHARE OF INFECTIOUS DISEASE POC RAPID TEST
MANUFACTURERS, 2011
- Figure 24: FORECAST OF THE GLOBAL INFECTIOUS DISEASE POC RAPID TEST
MARKET, 2008-2016
- Figure 25: MARKET SHARE FOR THE GLOBAL POC PREGNANCY/FERTILITY MARKET BY
TEST TYPE, 2011
- Figure 26: RELATIVE MARKET SHARE OF PREGNANCY/FERTILITY POC RAPID TEST
MANUFACTURERS, 2011
- Figure 27: FORECAST OF THE GLOBAL HEMOGLOBIN/HEMOSTASIS POC RAPID TEST
MARKET, THROUGH 2016
- Figure 28: RELATIVE MARKET SHARE OF HEMOGLOBIN/HEMOSTASIS POC RAPID TEST
MANUFACTURERS, 2011
- Figure 29: FORECAST OF THE GLOBAL TUMOR MARKER POC RAPID TEST MARKET,
THROUGH 2016
- Figure 30: RELATIVE MARKET SHARE OF TUMOR MARKER POC RAPID TEST
MANUFACTURERS, 2011
- Figure 31: FORECAST OF THE GLOBAL POC URINE CHEMISTRY ANALYZER MARKET,
2009-2016
- Figure 32: RELATIVE MARKET SHARE OF POC URINE CHEMISTRY ANALYZER
MANUFACTURERS, 2011
- Figure 33: U.S. PATENTS BY POC CATEGORIES, JANUARY 2009 TO NOVEMBER 2011
- Figure 34: U.S. PATENTS BY SUBJECT AREA, JANUARY 2009 TO NOVEMBER 2011
- Figure 35: GLOBAL FORECAST FOR THE POC MARKET, THROUGH 2016
- Figure 36: POC GLOBAL MARKET SHARE BY REGION, 2011
- Figure 37: NORTH AMERICAN POC MARKET SHARE BY COUNTRY, 2011
- Figure 38: EUROPEAN POC MARKET SHARE BY COUNTRY, 2011
- Figure 39: ASIAN POC MARKET SHARE BY COUNTRY, 2011
- Figure 40: MARKET SHARE MAJOR POC MARKET PARTICIPANTS, 2011
- Figure 41: ABAXIS' COMPANY REVENUES, 2006-2010*
- Figure 42: ABBOTTS' COMPANY REVENUES, 2006-2010
- Figure 43: ALERE'S COMPANY REVENUES 2006 - 2010
- Figure 44: BECKMAN COULTER'S COMPANY REVENUES, 2006-2010
- Figure 45: BECTON DICKINSON'S COMPANY REVENUES, 2006-2011*
- Figure 46: CHURCH & DWIGHT'S COMPANY REVENUES, 2006-2010
- Figure 47: DANAHER'S COMPANY REVENUES, 2006 - 2010
- Figure 48: QUEST'S COMPANY REVENUES, 2006-2010
- Figure 49: ITC'S COMPANY SALES, 2008-2010
- Figure 50: JOHNSON & JOHNSON'S COMPANY REVENUES, 2006-2010
- Figure 51: NIPRO CORPORATION'S COMPANY REVENUES, 2006-2010*
- Figure 52: ORASURE'S COMPANY REVENUES, 2006-2010
- Figure 53: QUIDEL'S COMPANY REVENUES, 2006-2010
- Figure 54: ROCHE GROUP'S REVENUES, 2006-2010
- Figure 55: SEKISUI CHEMICAL CO'S REVENUES, 2006-2010
- Figure 56: SIEMENS' COMPANY REVENUES, 2006-2010
- Figure 57: SPECTRAL'S COMPANY REVENUES, 2007-2010
- Figure 58: TRINITY'S COMPANY REVENUES, 2006-2010
2014年全球重點照護檢驗(POC)市場為165億美元規模
2012年02月07日
Global Information, Inc.已開始銷售BCC Research所發行的報告書「Point of Care Diagnostics (全球醫護站(POC)診斷市場)」
2011年重點照護檢驗(POC)的全球市場是138億美元規模，預測之後以複合年成長率(CAGR)3.7％擴大，2016年時達到165億美元。
依據檢查內容，重點照護檢驗(POC)市場可分成血糖值檢驗、血液化學及電解質檢驗、妊娠•懷孕能力試驗、心臟標記檢驗、藥物•酒精中毒檢驗、感染症檢驗，膽固醇檢驗、血紅素/止血、尿化學檢驗、以及腫瘤標記檢驗10個部門。
血糖值檢驗是該市場的最大部門，2011年為75億美元的市場規模，預計之後以CAGR 0.3％成長，2016年時達到76億美元規模。
血液化學及電解質檢驗部門是第二大部門，2011年的市場約為23億美元規模，預計之後以CAGR 4.8％成長，2016年時達到約29億美元。
預測最迅速成長的是心臟標記檢驗部門，2011年為10億美元規模，之後以CAGR 14.4％成長，2016年時達到20億美元。
預測感染症檢驗及腫瘤標記部門是接著會大幅成長的部門，將以CAGR 10％以上擴大。
全球性診斷檢驗事業是競爭激烈、成長率高、有數十億美元規模的產業。
診斷檢驗市場中，美國是最大市場。
本調查聚焦於診斷產業中最活躍的部門之一，即POC檢驗。POC檢驗是在家庭進行檢驗，而且是在患者附近進行的檢驗，故逐漸成長中，此2個部門亦成為本市場調查的對象。
|
